These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
472 related items for PubMed ID: 9168433
21. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia]. González FA, Villegas A, Ferro MT, San Román C, Sáez I, López M, del Potro E, Alvarez A, Martínez R, Díaz Madiavilla J. Med Clin (Barc); 1993 Oct 30; 101(14):521-4. PubMed ID: 8231395 [Abstract] [Full Text] [Related]
22. [Genetic diagnosis of chronic myeloid leukemia]. Kato C, Naoe T. Nihon Rinsho; 2001 Dec 30; 59(12):2336-41. PubMed ID: 11766335 [Abstract] [Full Text] [Related]
23. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia]. Matolcsy A. Orv Hetil; 2004 Dec 26; 145(52):2603-9. PubMed ID: 15724695 [Abstract] [Full Text] [Related]
24. The molecular pathology of chronic myelogenous leukaemia. Kurzrock R, Talpaz M. Br J Haematol; 1991 Oct 26; 79 Suppl 1():34-7. PubMed ID: 1931706 [Abstract] [Full Text] [Related]
26. Absence in Ph-negative, M-BCR rearrangement-positive chronic myelogenous leukemia of linkage between 5' ABL and 3' M-BCR sequences in Philadelphia translocation. Nishigaki H, Misawa S, Inazawa J, Abe T. Leukemia; 1992 May 26; 6(5):385-92. PubMed ID: 1593904 [Abstract] [Full Text] [Related]
27. Philadelphia-negative chronic myeloid leukaemia: detection by FISH of BCR-ABL fusion gene localized either to chromosome 9 or chromosome 22. Nacheva E, Holloway T, Brown K, Bloxham D, Green AR. Br J Haematol; 1994 Jun 26; 87(2):409-12. PubMed ID: 7947289 [Abstract] [Full Text] [Related]
29. Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: An Evolving Paradigm of Molecularly Targeted Therapy. Ali MA. Mol Diagn Ther; 2016 Aug 26; 20(4):315-33. PubMed ID: 27220498 [Abstract] [Full Text] [Related]